EquityZen Growth Technology Fund LLC - Series 1026
Raised
$1M
Investors
78
Min Invest
$10,023
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1026 is a Delaware-based pooled investment fund filed by EquityZen Advisors that raised $1.4M from 78 investors under Rule 506(b) and Section 3(c)(1) exemptions. The fund has a $10K minimum investment and operates as part of EquityZen's pre-IPO investment platform, which manages over 1,800 related entities providing access to private growth companies.
This pre-IPO fund follows the standard EquityZen platform template: a 506(b) private placement combined with 3(c)(1) exemption for pooled vehicles, targeting accredited investors with a $10K minimum. The relatively small average check size ($17,949 per investor) and high investor count reflect EquityZen's retail-accessible positioning within the pre-IPO secondary market category.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
